Benzinga  Sep 27  Comment 
Following the departure of CEO Joseph Papa, along with the subsequent 17 percent cut in the 2016 earnings guidance and the associated uncertainty regarding its strategy, Perrigo Company plc Ordinary Shares (NYSE: PRGO) have taken a hit. Argus’...
Forbes  Sep 22  Comment 
Looking at the sectors faring best as of midday Thursday, shares of Healthcare companies are outperforming other sectors, higher by 0.8%. Within the sector, Perrigo Company plc (NYSE: PRGO) and Mylan NV (NASD: MYL) are two of the day's stand-outs,...
FiercePharma  Sep 21  Comment 
Teva, Perrigo and Sun join list of suitors checking out Bayer's $1.1B derm unit chelfand Wed, 09/21/2016 - 11:25
Benzinga  Sep 19  Comment 
Barclays said in a research note that it sees 44–48 percent upside in Perrigo Company plc Ordinary Shares (NYSE: PRGO) to $131–$138, given its view that a more focused company could optimize performance of its consumer healthcare and branded...
FiercePharma  Sep 19  Comment 
Perrigo steps up Tysabri sale plans at activist’s urging chelfand Mon, 09/19/2016 - 08:39
Reuters  Sep 16  Comment 
Perrigo Company Plc , the manufacturer of generic drugs and over the counter medicines targeted by activist investor Starboard Value LP, is exploring a sale of the royalties from its multiple sclerosis drug Tysabri, people familiar with the matter...
Benzinga  Sep 13  Comment 
Activist investor Starboard Value wrote a letter on Monday to Perrigo Company plc Ordinary Shares (NYSE: PRGO), in which it implored the company to take steps to boost shareholder value as its stock is "deeply undervalued." Starboard's words...
Benzinga  Sep 13  Comment 
Monday was a busy day for the hedge fund sector as several notable firms issued public letters. Corvex Management To Williams' New Board Members Keith Meister's Corvex Management is one of the largest shareholders of Williams Companies Inc...


Perrigo Company is a global health-care supplier and the world's largest manufacturer of over-the-counter pharmaceuticals for the store brand market. The company develops, distributes, and manufactures over-the-counter and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients, and consumer products.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki